Weekly Digest – July 2025 Weekly Digest – July 2025 16 July 2025: Nature Medicine published Phase 1 results of Innovent Biologics’ anti-CLDN18.2 ADC (IBI343) in patients with advanced gastric/gastroesophageal junction adenocarcinoma Phase 1 results of Innovent Biologics’ anti-CLDN18.2 ADC, […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id